Hologic Executive and Leadership Team

MaryJo Griffin, the Special Advisor To Chairman, President and Chief Executive Officer at Hologic, provides strategic counsel and supports key executive initiatives. This advisory role involves offering insights on corporate strategy, market dynamics, and operational enhancements to senior leadership. Griffin's contributions are crucial in guiding Hologic's focus on improving women's health through early detection and treatment solutions. By leveraging extensive experience, MaryJo Griffin assists in navigating complex business challenges and identifying new opportunities for growth and innovation. The Special Advisor's function is to ensure alignment with the Chairman, President, and CEO's vision and objectives.

Karleen Oberton, the Chief Financial Officer at Hologic, directs all financial operations and strategic fiscal planning. Overseeing budgeting, forecasting, and capital allocation, Oberton ensures robust financial health and supports the company's growth initiatives. This leadership role involves managing investor relations and maintaining compliance with financial regulations across global markets. By optimizing resource deployment, Karleen Oberton directly contributes to Hologic's mission of improving women's health through advanced medical technologies. The Chief Financial Officer's oversight extends to financial reporting and driving operational efficiencies that align with corporate objectives.

Herm Rosenman, the Senior VP, Finance & Chief Financial Officer, Finance at Hologic, manages critical financial functions and supports the overall fiscal strategy. This role involves detailed oversight of financial planning, analysis, and reporting, ensuring accuracy and compliance across all financial activities. Rosenman's expertise is instrumental in guiding Hologic's financial performance and supporting its mission to advance women's health solutions. By collaborating with the Chief Financial Officer, Herm Rosenman contributes to optimizing financial resources and driving sustainable business growth. The Senior VP, Finance's focus includes enhancing financial controls and supporting strategic investment decisions.

Essex Mitchell, the Chief Operating Officer at Hologic, orchestrates global operational strategies and execution. Directing manufacturing, supply chain management, and operational excellence programs, Mitchell ensures efficient production and delivery of Hologic's medical technologies. This critical role involves optimizing processes to enhance product quality and meet market demand across diverse regions. By driving operational improvements, Essex Mitchell directly supports the company's commitment to advancing women's health and wellbeing. The Chief Operating Officer's focus includes fostering a culture of continuous improvement and ensuring seamless integration of new technologies into existing workflows.

Jennifer Schneiders, the President, Diagnostic Solutions at Hologic, directs the strategic development and commercialization of the company's diagnostic product portfolio. Overseeing research, product innovation, and market expansion for diagnostic testing, Schneiders drives Hologic's leadership in early detection and disease management. This position is key to advancing women's health by providing cutting-edge solutions for infectious diseases and other critical health areas. By fostering collaboration across R&D and sales teams, Jennifer Schneiders ensures diagnostic offerings meet evolving healthcare needs globally. The President, Diagnostic Solutions' focus includes enhancing market penetration and driving revenue growth for this vital business segment.

Jan Verstreken, the Group President, International at Hologic, leads the company's strategic operations and market growth across all global regions outside the United States. Overseeing sales, marketing, and business development initiatives in diverse international markets, Verstreken ensures Hologic's advanced medical technologies reach a wider patient population. This role is critical for expanding Hologic's impact on women's health worldwide. By adapting strategies to local market needs and regulatory environments, Jan Verstreken drives consistent revenue growth and strengthens the company's global presence. The Group President, International's focus includes building strong partnerships with healthcare providers and distributors internationally.

Mark Horvath, the President, Breast & Skeletal Health Solutions at Hologic, spearheads the strategic direction and commercial success of the company's core product lines. Directing innovation, product development, and market strategies for breast health and skeletal health diagnostics and imaging, Horvath reinforces Hologic's commitment to early detection and treatment. This leadership position is central to improving outcomes for women facing critical health challenges. By driving market leadership and fostering strong customer relationships, Mark Horvath ensures Hologic remains at the forefront of women's health solutions. The President, Breast & Skeletal Health Solutions' focus includes expanding access to essential screening and diagnostic tools globally.

Paul Malenchini, the Chief Information Officer at Hologic, leads the company's global information technology strategy and infrastructure. Overseeing digital transformation initiatives, cybersecurity, and data management, Malenchini ensures robust and secure technological operations. This position is vital for supporting Hologic's innovation in diagnostic products, imaging systems, and surgical tools. By implementing advanced IT solutions, Paul Malenchini enhances operational efficiency and facilitates data-driven decision-making across all business units. The Chief Information Officer's responsibilities include aligning technology investments with strategic business goals and safeguarding sensitive company and patient data.